The effect of platelet-rich plasma on early and late bone healing using a mixture of particulate autogenous cancellous bone and Bio-Oss®: an experimental study in goats

Platelet-rich plasma (PRP), containing various growth factors, may speed up wound and bone healing. Using osteoconductive alloplastic materials in reconstructive surgery, the amount of autogenous bone needed can be reduced. The purpose of this experiment was to study the effect of PRP on a mixture of autogenous bone and deproteinized bovine bone mineral (Bio-Oss^®) particles in goats. Four, round, critical size defects were made in the foreheads of 20 goats. In all goats the defects were filled with a mixture of autogenous particulate cancellous bone and (Bio-Oss^®) particles, in which 1 ml of PRP was added in two of the four defects. The goats were allocated to four subgroups each containing five goats, which were killed after 1, 2, 6 and 12 weeks. The results of the histological and histomorphometric examination showed that early and late bone healing were not enhanced when PRP was used.     

Applicability of equine hydroxyapatite collagen (eHAC) bone blocks for lateral augmentation of the alveolar crest. A histological and histomorphometric analysis in rats

This study assessed the mechanical characteristics, biocompatibility and osteoconductive properties of an equine hydroxyapatite collagen (eHAC) bone block when applied as a bone substitute for lateral augmentation of rat mandible. 96 rats underwent lateral augmentation of the mandible, using two substitute bone blocks (eHAC or Bio-Oss^® spongiosa) or autologous bone grafts. Signs of inflammation, amount of bone formation and ingrowth of bone into the bone blocks were assessed at 1 and 3 months. eHAC blocks were mechanically rigid and could be fixed firmly and easily. Bio-Oss^® spongiosa blocks were brittle and fixation was difficult. eHAC and Bio-Oss^® spongiosa blocks were biocompatible and induced few or no signs of inflammation. Inflammation prevalence between the groups was not statistically different. Bone formation and bone growth into the blocks was significantly higher in eHAC than Bio-Oss^® spongiosa blocks, but lower than in autologous bone grafts (after 1 and 3 months). Regression analysis showed that the autologous bone graft predicted new bone formation at both time points. The eHAC block was only a predictor at 1 month; a trend was found at 3 months. The application of biodegradable membranes was not related to more bone ingrowth.     

A comparative study of the regenerative effect of sinus bone grafting with platelet-rich fibrin-mixed Bio-Oss® and commercial fibrin-mixed Bio-Oss®: An experimental study

Anorganic bovine bone (Bio-Oss^®) particles are one of the most popular grafting materials. The particles are often mixed with platelet-rich fibrin (PRF) or a commercial fibrin (Tisseel^®) to form a mouldable graft material. The objective of this study was to compare the potentials of PRF-mixed Bio-Oss^® and Tisseel^®-mixed Bio-Oss^® to enhance bone regeneration in a canine sinus model. Six mongrel dogs were used in this study. After elevating the sinus membrane in both maxillary sinus cavities, an implant was placed into the sinus cavity. In one of the sinus cavities, the PRF/Bio-Oss^® composite was grafted, and the Tisseel^®/Bio-Oss^® composite was grafted in the other sinus cavity. After a 6 month healing period, bone formation in the graft sites and bone-implant contact were evaluated. The mean osseointegration rate was 43.5 ± 12.4% and new bone formation rate 41.8 ± 5.9% in the PRF/Bio-Oss^® composite sites. In the Tisseel^®/Bio-Oss^® composite sites they were 30.7 ± 7.9% and 31.3 ± 6.4%. There were statistically significant differences between the groups. The findings from this study suggest that when platelet-rich fibrin is used as an adjunct to Bio-Oss^® particles for bone augmentation in the maxillary sinus, bone formation in the graft sites is significantly greater than when Tisseel^® is used.     

Maxillary sinus floor augmentation and dental implant placement using dentin matrix protein-1 gene-modified bone marrow stromal cells mixed with deproteinized boving bone: A comparative study in beagles

ObjectiveThe aim of the study was to evaluate the effects of the combined use of dentin matrix protein-1 (DMP1) gene-modified bone marrow stromal cells (BMSCs) and Bio-Oss^® for maxillary sinus floor augmentation (MSFA) implant placement in dogs.Materials and methodsBMSCs were derived from bone marrow of six beagles and cultured. The cells were transduced with a lentiviral vector overexpressing the DMP1 gene and enhanced green fluorescent protein (EGFP) gene (Lenti-DMP1/EGFP) in test group, and with a lentiviral vector encoding EGFP gene (Lenti-EGFP) in control group. Six dogs received sinus augmentations using the bilateral approach with a simultaneous implant placement at each site respectively. At the same concentration, 2 × 10⁷ cells/ml, one sinus was grafted using a mixture of autologous DMP1/EGFP gene-modified BMSCs and Bio-Oss^® (DMP1 group), and the contralateral sinus was grafted with autologous EGFP gene-modified bMSCs and Bio-Oss^® (EGFP group). After a 3 month healing period, bone regeneration and osseointegration were evaluated using histologic and histomorphometric methods.ResultsThe bone-implant contact (BIC) and the bone area fraction in the DMP1 group (BIC: 34.67% ± 8.23%, bone area fraction: 35.16% ± 3.32%) were significantly greater compared with the EGFP group (BIC: 26.06% ± 5.16%, bone area fraction: 20.74% ± 1.63%) (P < 0.05). No significant difference between the residual bone substitute material volume (BSMV) in the DMP1 group (35.86 ± 7.35) and the EGFP group (32.16 ± 9.16) was found in our study (P > 0.05).ConclusionBMSCs modified with the DMP1 gene can be used as an adjunct to Bio-Oss^® to enhance new bone formation and the osseointegration of dental implants in MSFA of dogs.     

Effect of grafting materials on osseointegration of dental implants surrounded by circumferential bone defects. An experimental study in the dog

Aims: This study was designed to evaluate the effect of gap width and graft placement on bone healing around implants placed into simulated extraction sockets in the mandibles of four beagle dogs. Materials and methods: Four Ti‐Unite^® implants (13 mm × 3.3 mm) were placed on each side of the mandible. Three implants were surrounded by a 1.35 mm circumferential and a 5 mm deep gap around the coronal portion of the implants. A fourth implant was inserted conventionally into both sides of the mandibles as a positive control. The gaps were filled with either Bio‐Oss^®, autogenous bone or with a blood clot alone. The study design was balanced for animal, side and modality. Ground sections were prepared from biopsies taken at 3 months, and computer‐aided histometric measurements of bone/implant contact and area of bone within threads were made for the coronal 5 mm. Data were analysed using analysis of variance. Results: The mean bone/implant contact was 9.8 mm for the control and ranged from 9.3 to 11.3 mm for the three test modalities. The corresponding values for area within threads were 1 mm² and 1–1.2 mm². Modality had a significant effect on both bone/implant contact (F=16.9; P<0.0001) and area within threads (F=16.7; P<0.0001). Conclusion: The results of this study suggest that both autogenous bone graft and Bio‐Oss^® played an important role in the amount of hard tissue fill and osseointegration occurring within marginal bone defects around implants.     

The effect of permanent grafting materials on the preservation of the buccal bone plate after tooth extraction: an experimental study in the dog

Objectives: The aim of the present study was to evaluate the effects of a novel bone substitute system (Natix^®), consisting of porous titanium granules (PTG) and a bovine‐derived xenograft (Bio‐Oss^®), on hard tissue remodelling following their placement into fresh extraction sockets in dogs. Material and methods: Six modalities were tested; Natix^® granules with and without a covering double‐layered Bio Gide^® membrane; Bio‐Oss^® with and without a covering double‐layered Bio Gide^® membrane; and a socket left empty with and without a covering double‐layered Bio Gide^® membrane. Linear measurements, indicative of buccal bone height loss, and an area measurement indicative of buccal bulk bone loss were made. The statistical analysis was based on the Latin Square design with two blocking factors (dog and site). Tukey's post hoc test was used to adjust for multiple comparisons. Results: Histological observation revealed that while bone formed around both the xenograft and the titanium particles, bone was also noted within titanium granules. Of the five modalities of ridge preservation techniques used in this study, no one technique proved to be superior. Conclusion: The titanium granules were observed to have promising osseoconductive properties. To cite this article:
Bashara H, Wohlfahrt JC, Polyzois I, Lyngstadaas SP, Renvert S, Claffey N. The effect of permanent grafting materials on the preservation of the buccal bone plate after tooth extraction: an experimental study in the dog.
Clin. Oral Impl. Res. 23 , 2012; 911–917
doi: 10.1111/j.1600‐0501.2011.02240.x     

A prospective histomorphometric and cephalometric comparison of bovine bone substitute and autogenous bone grafting in Le Fort I osteotomies

Purpose

The aim of the present study was the histomorphometric and cephalometric comparison of autogenous bone grafting of the anterior iliac crest and the application of bovine bone substitute concerning new bone formation and postoperative stability in patients undergoing orthognathic Le Fort I osteotomy.

Le Fort I osteotomies using Bio-Oss® Collagen to promote bony union: a prospective clinical split-mouth study

The purpose of this study was to evaluate whether a bone substitute can be used to promote bony union in patients undergoing maxillary advancement after Le Fort l osteotomy. Nine patients were treated bilaterally with Le Fort I osteotomies and maxillary advancements of 5 mm or less. In each patient, one gap was grafted with the bone substitute Bio-Oss^® Collagen (BOC). The contralateral site was left empty and served as control. After 6 months there were still empty gaps in the control sites of three patients, while in the grafted sites all gaps were completely filled with bone. The histomorphometric analysis performed with biopsies from the region of the original gap showed a similar amount of new bone in both groups, however, in the test group the mean overall amount of the mineralized fraction was higher compared to the control group (test site 65.0 ± 6.2%, control site 38.9 ± 32.6%). The bone substitute seemed to be a suitable material to promote bony union in Le Fort I osteotomies. Further studies are needed to analyse whether this technique is efficient in preventing relapse and promoting bony union in larger advancements.     

Effect of surface contamination on osseointegration of dental implants surrounded by circumferential bone defects

Objective: This study was designed to evaluate the effect of surface contamination on osseointegration of dental implants surrounded by a circumferential bone defect and to compare osseointegration around Osseotite® with that around Nanotite^? implants. Materials and methods: The premolars on both sides of the mandible in four beagle dogs were extracted. Following 4 months healing, two Nanotite^? implants and two Osseotite® implants were partially inserted in the left side of each mandible. Some threads protruded from the tissues into the oral cavity. Following a 5 week healing period, the implants were removed and the contaminated part of each implant was cleaned. They were then installed to the full implant length on the contra lateral side of the mandibles. The coronal 5 mm of each implant was surrounded by 1 mm circumferential bone defect. Following 12 weeks of healing period, the dogs were sacrificed and biopsies were obtained. Ground sections were prepared for histomorphometric analysis. Results: All implants were associated with direct bone‐to‐implant contact on the portion of the implant surface contaminated previously and surrounded by bone defect. Nanotite^? implants performed better than Osseotite® implants. Conclusions: The results demonstrated that implant surfaces, which were contaminated previously and were surrounded by bone defects, can osseointegrate. To cite this article:
Mohamed S, Polyzois I, Renvert S, Claffey N. Effect of surface contamination on osseointegration of dental implants surrounded by circumferential bone defects. Clin. Oral Impl. Res. 21 , 2010; 513–519.
doi: 10.1111/j.1600‐0501.2010.01913.x     

Effect of rhBMP-2 on guided bone regeneration in humans

Abstract: The aim of the present clinical study was to test whether or not the addition of recombinant human bone morphogenetic protein‐2 (rhBMP‐2) to a xenogenic bone substitute mineral (Bio‐Oss^®) will improve guided bone regeneration therapy regarding bone volume, density and maturation. In 11 partially edentulous patients, 34 Brånemark implants were placed at two different sites in the same jaw (five maxillae, six mandibles) requiring lateral ridge augmentation. The bone defects were randomly assigned to test and control treatments: the test and the control defects were both augmented with the xenogenic bone substitute and a resorbable collagen membrane (Bio‐Gide^®). At the test sites, the xenogenic bone substitute mineral was coated with rhBMP‐2 in a lyophilization process. Following implant insertion (baseline), the peri‐implant bone defect height was measured from the implant shoulder to the first implant–bone contact. After an average healing period of 6 months (SD 0.17, range 5.7–6.2), the residual defects were again measured and trephine burs were used to take 22 bone biopsies from the augmented regions. The healing period was uneventful except for one implant site that showed a wound dehiscence, which spontaneously closed after 4 weeks. Later at reentry, all implants were stable. At baseline, the mean defect height was 7.0 mm (SD 2.67, range 3–12 mm) at test and 5.8 mm (SD 1.81, range 3–8 mm) at control sites. At reentry, the mean defect height decreased to 0.2 mm (SD 0.35, range 0–1 mm) at test sites (corresponding to 96% vertical defect fill) and to 0.4 mm (SD 0.66, range 0–2 mm) at the control site (vertical defect fill of 91%). Reduction in defect height from baseline to reentry for both test and control sites was statistically significant (Wilcoxon P<0.01). Histomorphometric analysis showed an average area density of 37% (SD 11.2, range 23–51%) newly formed bone at test sites and 30% (SD 8.9, range 18–43%) at control sites. The fraction of mineralized bone identified as mature lamellar bone amounted to 76% (SD 14.4, range 47.8–94%) at test compared to 56% (SD 18.3, range 31.6–91.4%) at control sites (paired t‐test P<0.05). At BMP‐treated sites 57% (SD 16.2, range 29–81%) and at control sites 30% (SD 22.6, range 0–66%) of the surface of the bone substitute particles were in direct contact with newly formed bone (paired t‐test P<0.05). It is concluded that the combination of the xenogenic bone substitute mineral with rhBMP‐2 can enhance the maturation process of bone regeneration and can increase the graft to bone contact in humans. rhBMP‐2 has the potential to predictably improve and accelerate guided bone regeneration therapy.     

Bone healing in critical-size defects treated with either bone graft, membrane, or a combination of both materials: a histological and histometric study in rat tibiae

Objectives: The aim of the present investigation was to histologically analyze the effect of using lyophilized bovine bone (GenOx^® organic matrix) with (or without) guided tissue regeneration (using a decalcified cortical osseous membrane [GenDerm^®]) on bone healing in surgically created critical‐size defects created in rat tibia. Material and methods: Surgical critical‐size bone defects were created in 64 animals that were randomly divided into four groups: group I (control); group II (defect filled with GenOx^®); group III (defect covered by GenDerm^®); group IV (defect filled with GenOx^® and covered by GenDerm^®). Animals were killed at 30 or 90 days post‐surgery. The specimens were embedded in paraffin, serially cut, and stained with hematoxylin and eosin for analysis under light microscopy. The formation of new bone in the cortical area of the defect was histomorphometrically evaluated. Results: All experimental groups demonstrated superior bone healing compared with the control group. However, group IV samples showed evidence of more advanced healing at both 30 and 90 days post‐surgery as compared with the other experimental groups. Conclusions: The bovine organic bone graft GenOx^® associated with GenDerm^® this produced the best treatment results in the case of critical‐size defects in rat tibia. To cite this article :
Bernabé PFE, Melo LGN, Cintra LTA, Gomes‐Filho JE, Dezan E Jr, Nagata MJH. Bone healing in critical‐size defects treated with either bone graft, membrane, or a combination of both materials: a histological and histometric study in rat tibiae.
Clin. Oral Impl. Res. 23 , 2012; 384–388.
doi: 10.1111/j.1600‐0501.2011.02166.x     

Bone healing around implants placed in a jaw defect augmented with Bio-Oss. An experimental study in dogs

The present experiment was carried out to study some tissue reactions around implants that were placed in an edentulous ridge which had been augmented with deproteinized natural bovine cancellous bone mineral. In 4 male beagle dogs, the premolars in the right side of the mandible were extracted and a large buccal ridge defect was created by mechanical means. The bone plate at the lingual aspect of the defect was left intact. 5 months later, the distal 2/3 of the defect area was augmented with Bio‐Oss^® (Geistlich Sons Ltd, Wolhusen, Switzerland) mixed with a fibrin sealer (Tisseel^®, Immuno AG, Vienna, Austria). After 3 months of healing, 3 fixtures (Astra Tech AB, Mölndal, Sweden; TiO‐blast; 8×3.5 mm) were installed in the mandible; 2 were placed in the augmented portion and 1 was placed in the non‐augmented portion of the defect. After a healing period of 3 months, abutment connection was performed and a plaque control period initiated. 4 months later, the dogs were sacrificed and each implant region was dissected. The tissue samples were dehydrated, embedded in plastic, sectioned in the bucco‐lingual plane and examined in the light microscope. It was observed that osseointegration failed to occur to implant surfaces within an alveolar ridge portion previously augmented with Bio‐Oss^®. In the augmented portion of the crest, the graft particles were separated from the host tissue as well as from the implant by a well‐defined connective tissue capsule. Although the lingual aspect of all fixtures (test and control) was in contact with hard tissue at the time of installation, after 4 months of function, a deep vertical bone defect frequently had formed at the lingual surface of the implants. It was concluded that in this model (i) Bio‐Oss^® failed to integrate with the host bone tissue and (ii) no osseointegration occurred to the implants within the augmented portion of the crest.     

Bone substitute as an on‐lay graft on rat tibia

Objectives: To investigate the capacity of Cerament^®, an injectable bone substitute, to guide bone generation from a cortical surface. Materials and method: Cerament^® was applied to the cortical surface of rat tibiae and investigated histologically after 3, 6 and 12 weeks, using a procedure similar to that performed in sham‐operated rats. Results: In both groups, the thickness of the bone cortex increased significantly from 473±58 μm (mean±SD) at day 0 to 1193±255 μm (Cerament^®) and 942±323 μm (sham) after 3 weeks. In the Cerament^® group, the new bone thickness remained constant (1258±288 μm) until the end of the experiment at 12 weeks, while the sham group demonstrated a return to initial cortical thickness (591±73 μm) at 12 weeks. The newly formed bone in the Cerament^® group was highly trabecular after 3 weeks but attained a normal trabecular structure of the cortex after 12 weeks. Conclusion: Cerament^® may guide bone generation from an intact cortical bone surface. Although bone remodeling speed may differ between rats and humans, our study indicates that Cerament^® may become a useful alternative to autologous bone, both to fill defects and to increase bone volume by cortical augmentation. To cite this article:
Truedsson A, Wang J‐S, Lindberg P, Gordh M, Sunzel B, Warfvinge G. Bone substitute as an on‐lay graft on rat tibia. Clin. Oral Impl. Res. 21 , 2010; 424–429.
doi: 10.1111/j.1600‐0501.2009.01875.x     

Effect of pulverized natural bone mineral on regeneration of three-wall intrabony defects. A preclinical study

Aims

The objective of this study is to evaluate the effects of a paste-like bone substitute material with easy handling properties and improved mechanical stability on periodontal regeneration of intrabony defects in dogs.

Materials and methods

Mandibular and maxillary first and third premolars were extracted, and three-wall intrabony defects were created on second and fourth premolars. After a healing period of 3 months, acute type defects were filled with a paste-like formulation of deproteinized bovine bone mineral (DBBM) (particle size, 0.125–0.25 mm) in a collagenous carrier matrix (T1), pulverized DBBM (particle size, 0.125–0.25 mm) without the carrier (T2), or Bio-Oss® granules (particle size, 0.25–1.00 mm) as control (C). All defects were covered with a Bio-Gide® membrane. The dogs were sacrificed after 12 weeks, and the specimens were analyzed histologically and histometrically.

Results

Postoperative healing of all defects was uneventful, and no histological signs of inflammation were observed in the augmented and gingival regions. New cementum, new periodontal ligament, and new bone were observed in all three groups. The mean vertical bone gain was 3.26 mm (T1), 3.60 mm (T2), and 3.81 mm (C). That of new cementum was 2.25 mm (T1), 3.88 mm (T2), and 3.53 mm (C). The differences did not reach statistical significance. The DBBM particles were both incorporated in new bone and embedded in immature bone marrow.

Conclusions

The results of this preclinical study showed that the 0.125–0.25-mm DBBM particles in a powder or paste formulation resulted in periodontal regeneration comparable to the commercially available DBBM. Osteoconductivity, in particular, was not affected by DBBM size or paste formulation.

Clinical relevance

The improved handling properties of the paste-like bone substitute consisting of small DBBM particles embedded in a collagen-based carrier hold promise for clinical applications.     

Paste-like inorganic bone matrix: preclinical testing of a prototype preparation in the porcine calvaria

Objective: To evaluate the osteoconductive properties and the volume stability of an injectable paste‐like inorganic bone matrix (PBM) in porcine calvaria defects. Material and methods: We created six circumferential defects in the calvaria of 12 adult iberico pigs. The defects were filled with either PBM, Bio‐Oss® of different particle size, carrier alone, or left empty. PBM was composed of Bio‐Oss® with a particle size ranging from 250 to 500 μm and a hydrogel‐carrier of carboxymethylcellulose and collagen. After 6 and 12 weeks of healing, the animals were sacrificed and undecalcified ground sections were prepared and subjected to histologic and histomorphometric analysis. To quantify the osteoconductive properties of PBM, bone volume per tissue volume (BV/TV) in the defect area was determined. To determine the volume stability, bone substitute volume per tissue volume (BSV/TV) was measured. Results: After 6 weeks, PBM particles in the center of the defect were surrounded by fibrous connective tissue, which was later replaced by bone. BV/TV in the PBM group increased from 29.7±12.7% (minimum 12.2%, maximum 43.7%) after 6 weeks to 43.9±14.9% (minimum 27.8%, maximum 63.9%) after 12 weeks (Mann–Whitney test; P=0.6). According to the Friedman test, BV/TV in groups containing Bio‐Oss® of different particle sizes, the carrier and the empty defects was similar to the results obtained with PBM (6 weeks P=0.8; 12 weeks P=0.22). BSV/TV in the PBM group was stable over time, with 10.1±9% (minimum 3.3%, maximum 27.6%) and 16.5±12.9% (minimum 1%, maximum 32.7%), after 6 and 12 weeks, respectively (P=0.72). BSV/TV in the PBM group was comparable to the results obtained with the Bio‐Oss® particles of different sizes (Friedman test; 6 weeks P=0.0503; 12 weeks P=0.56). Conclusions: The results of this preclinical study showed that the PBM is osteoconductive and maintains the augmented volume, similar to commercial Bio‐Oss®. These data suggest that the osteoconductive properties of Bio‐Oss® are maintained at the smaller particle size and in the presence of the carrier.     

Effect of implant surface properties on peri-implant bone healing: a histological and histomorphometric study in dogs

Aim: The present study aimed to evaluate and compare two types of implants, i.e. grit‐blasted and acid‐etched implants (SLActive^®) with nano‐meter‐scale hydroxyapatite surface‐modified implants (NanoTite^?). Material and methods: For histological and histomorphometrical evaluation, 22 SLActive^® and 22 Nanotite^? implants were inserted in eleven Beagle dogs. The animals were divided into three groups of healing (A: 2 weeks; B: 4 weeks and C: 8 weeks). Two, 4 and 8 weeks after implantation, the animals were sacrificed and bone‐to‐implant contact (BIC %), first implant–bone contact (1st BIC) as well as amount of bone (BV) were assessed. Results: For SLActive^® and Nanotite^? implants, BIC% increased significantly over time. No statistically significant differences in BIC% were found between SLActive^® and Nanotite^? at all the respective implantation times. Moreover, for the different healing periods, no significant differences for BV between SLActive^® and Nanotite^? implants were found. Conclusions: The present study showed that SLActive^® and NanoTite^? implants induce a similar bone response after implantation for 2, 4 and 8 weeks in a non‐submerged position in the mandible of dogs. To cite this article:
Al‐Hamdan K, Al‐Moaber SH, Junker R, Jansen JA. Effect of implant surface properties on peri‐implant bone healing: a histological and histomorphometric study in dogs.
Clin. Oral Impl. Res. 22 , 2011; 399–405.     

Oral implants placed in bone defects treated with Bio‐Oss®, Ostim®‐Paste or PerioGlas: an experimental study in the rabbit tibiae

Objectives: To compare the histological features of bone filled with Bio‐Oss^®, Ostim‐Paste^® or PerioGlas placed in defects in the rabbit tibiae by evaluating bone tissue composition and the integration of titanium implants placed in the grafted bone. Material and methods: Two cylindrical bone defects, about 4 mm in diameter and 6 mm in depth, were created in the tibiae of 10 rabbits. The defects were filled with either Bio‐Oss^®, PerioGlas, Ostim^®‐Paste or left untreated, and covered with a collagen membrane. Six weeks later, one titanium sandblasted and acid‐etched (SLA) implant was inserted at the centre of each previously created defect. The animals were sacrificed after 6 weeks of healing. Results: Implants placed in bone previously grafted with Bio‐Oss^®, PerioGlas or Ostim^®‐Paste obtained a larger extent of osseointegration, although not statistically significant, than implants placed in non‐grafted bone. The three grafting materials seemed to perform in a similar way concerning their contribution towards implant osseointegration. All grafting materials appeared to be osteoconductive, thus leading to the formation of bridges of mineralized bone extending from the cortical plate towards the implants surface through the graft scaffold. Conclusions: Grafting with the above‐mentioned biomaterials did not add any advantage to the osseointegration of titanium SLA implants in a self‐contained defect.     

Maxillary sinus augmentation using xenogenic bone substitute material Bio-Oss in combination with venous blood. A histologic and histomorphometric study in humans

The aim of the present study was to evaluate bone formation following maxillary sinus augmentation using bovine bone substitute material Bio‐Oss^® in combination with venous blood by means of histologic and histomorphometric examination of human biopsies. This involved a total of 15 sinus floor elevation procedures being carried out on 11 patients (average age of 49.6 years) according to the technique described by Tatum (1986). The subantral sinus cavity was augmented using bovine apatite combined with venous blood. After an average healing phase of 6.8 months, trephine burrs were used to take 22 bone biopsies from the augmented sinus region. Then 38 Brånemark^® implants were inserted in both the osteotomies resulting from bone sampling and in regular sites in the augmented posterior maxilla. Histomorphometric analysis of ground sections from the bone biopsies prepared according to the standard method of Donath & Breuner (1982) produced an average percentage of newly‐formed bone of 14.7% (±5.0%) and a proportion of residual xenogenic bone substitute material of 29.7% (±7.8%). Some 29.1% (±8.1%) of the surface of the Bio‐Oss^® granulate was in direct contact with newly‐formed bone. Histologically, newly‐developed bone became evident, partly invaginating the particles of apatite and forming bridges in the form of trabeculae between the individual Bio‐Oss^® particles. Despite the absence of osteoclastic activity, the inward growth of bone indicates slow resorption of the xenogenic bone graft material. When the implants were uncovered, after an average healing phase of 6 months, 4 of the 38 implants had become loose. Of these 4 implants, 1 had to be subsequently explanted, while the others remained as “sleeping implants” and were not included in the implants superstructure. Thus, the resulting clinical survival rate, prior to prosthetic loading, was 89.5%.     

Guided bone generation in a rabbit mandible model after periosteal expansion with an osmotic tissue expander

Objectives: To evaluate the space‐maintaining capacity of titanium mesh covered by a collagen membrane after soft tissue expansion on the lateral border of the mandible in rabbits, and to assess bone quantity and quality using autogenous particulate bone or bone‐substitute (Bio‐Oss^®), and if soft tissue ingrowth can be avoided by covering the mesh with a collagen membrane. Material and methods: In 11 rabbits, a self‐inflatable soft tissue expander was placed under the lateral mandibular periosteum via an extra‐oral approach. After 2 weeks, the expanders were removed and a particulated onlay bone graft and deproteinized bovine bone mineral (DBBM) (Bio‐Oss^®) were placed in the expanded area and covered by a titanium mesh. The bone and DBBM were separated in two compartments under the mesh with a collagen membrane in between. The mesh was then covered with a collagen membrane. After 3 months, the animals were sacrificed and specimens were collected for histology. Results: The osmotic soft tissue expander created a subperiosteal pocket and a ridge of new bone formed at the edges of the expanded periosteum in all sites. After the healing period of 3 months, no soft tissue dehiscence was recorded. The mean bone fill was 58.1±18% in the bone grafted area and 56.9±13.7% in the DBBM area. There was no significant difference between the autologous bone graft and the DDBM under the titanium mesh with regard to the total bone area or the mineralized bone area. Scanning electron microscopy showed that new bone was growing in direct contact with the DBBM particles and the titanium mesh. There is a soft tissue ingrowth even after soft tissue expansion and protection of the titanium mesh with a collagen membrane. Conclusion: This study confirms that an osmotic soft tissue expander creates a surplus of periosteum and soft tissue, and that new bone can subsequently be generated under a titanium mesh with the use of an autologous bone graft or DBBM. To cite this article:
Abrahamsson P, Isaksson S, Andersson G. Guided bone generation in a rabbit mandible model after periosteal expansion with an osmotic tissue expander.
Clin. Oral Impl. Res. 22 , 2011; 1282–1288.
doi: 10.1111/j.1600‐0501.2010.02108.x     

Influence of bisphosphonate treatment on bone substitute performance in osteoporotic conditions

Objective

Considering the elevated number of osteoporotic patients in need of bone graft procedures, we here evaluated the effect of alendronate (ALN) treatment on the regeneration of bone defects in osteoporotic rats. Bone formation was histologically and histomorphometrically assessed in rat femoral condyle bone defects filled with bone graft (Bio-Oss®) or left empty.

Methods

Male Wistar rats were induced osteoporotic through orchidectomy (ORX) and SHAM-operated. The animals were divided into three groups: osteoporotic (ORX), osteoporotic treated with ALN (ORX + ALN) and healthy (SHAM). Six weeks after ORX or SHAM surgeries, bone defects were created bilaterally in femoral condyles; one defect was filled with Bio-Oss® and the other one left empty. Bone regeneration within the defects was analyzed by histology and histomorphometry after 4 and 12 weeks.

Results

Histological samples showed new bone surrounding Bio-Oss® particles from week 4 onward in all three groups. At week 12, the data further showed that ALN treatment of osteoporotic animals enhanced bone formation to a 10-fold increase compared to non-treated osteoporotic control. Bio-Oss® filling of the defects promoted bone formation at both implantation periods compared to empty controls.

Conclusion

Our histological and histomorphometric results demonstrate that the enteral administration of alendronate under osteoporotic bone conditions leverages bone defect regeneration to a level comparable to that in healthy bone. Additionally, Bio-Oss® is an effective bone substitute, increasing bone formation, and acting as an osteoconductive scaffold guiding bone growth in both healthy and osteoporotic bone conditions.

Significance

Based on the results of this study, enteral use of ALN mitigates adverse effects of an osteoporotic condition on bone defect regeneration.